The Karma system is currently undergoing maintenance (Monday, January 29, 2018).
The maintenance period has been extended to 8PM EST.

Karma Credits will not be available for redeeming during maintenance.

JMIR Public Health and Surveillance

Citing this Article

Right click to copy or hit: ctrl+c (cmd+c on mac)

Published on 03.02.17 in Vol 3, No 1 (2017): Jan-Mar

This paper is in the following e-collection/theme issue:

Works citing "HIV Trends in the United States: Diagnoses and Estimated Incidence"

According to Crossref, the following articles are citing this article (DOI 10.2196/publichealth.7051):

(note that this is only a small subset of citations)

  1. Demeke HB, Johnson AS, Wu B, Nwangwu-Ike N, King H, Dean HD. Differences Between U.S.-Born and Non-U.S.-Born Black Adults Reported with Diagnosed HIV Infection: United States, 2008–2014. Journal of Immigrant and Minority Health 2018;
    CrossRef
  2. Lesko CR, Lau B, Chander G, Moore RD. Time Spent with HIV Viral Load > 1500 Copies/mL Among Persons Engaged in Continuity HIV Care in an Urban Clinic in the United States, 2010–2015. AIDS and Behavior 2018;
    CrossRef
  3. Carey JW, Carnes N, Schoua-Glusberg A, Kenward K, Gelaude D, Denson D, Gall E, Randall LA, Frew PM. Barriers and Facilitators for Clinical Care Engagement Among HIV-Positive African American and Latino Men Who Have Sex with Men. AIDS Patient Care and STDs 2018;
    CrossRef
  4. Goodreau SM, Hamilton DT, Jenness SM, Sullivan PS, Valencia RK, Wang LY, Dunville RL, Barrios LC, Rosenberg ES. Targeting Human Immunodeficiency Virus Pre-Exposure Prophylaxis to Adolescent Sexual Minority Males in Higher Prevalence Areas of the United States: A Modeling Study. Journal of Adolescent Health 2018;62(3):311
    CrossRef
  5. Momplaisir F, Hussein M, Tobin-Fiore D, Smith L, Bennett D, Latkin C, Metzger DS. Racial Inequities in HIV Prevalence and Composition of Risk Networks Among People Who Inject Drugs in HIV Prevention Trial Network 037. JAIDS Journal of Acquired Immune Deficiency Syndromes 2017;76(4):394
    CrossRef
  6. Marks SJ, Merchant RC, Clark MA, Liu T, Rosenberger JG, Bauermeister J, Mayer KH. Potential Healthcare Insurance and Provider Barriers to Pre-Exposure Prophylaxis Utilization Among Young Men Who Have Sex with Men. AIDS Patient Care and STDs 2017;31(11):470
    CrossRef
  7. Lee AJ, Montgomery MC, Patel RR, Raifman J, Dean LT, Chan PA. Improving insurance and healthcare systems to ensure better access to sexually transmitted disease testing and prevention. Sexually Transmitted Diseases 2017;:1
    CrossRef
  8. Hurt CB, Nelson JA, Hightow-Weidman LB, Miller WC. Selecting an HIV Test. Sexually Transmitted Diseases 2017;44(12):739
    CrossRef
  9. Hoornenborg E, Krakower DS, Prins M, Mayer KH. Pre-exposure prophylaxis for MSM and transgender persons in early adopting countries. AIDS 2017;31(16):2179
    CrossRef
  10. Chan PA, Flanigan TP. Effective HIV Prevention Interventions and the Need for Rapid Mobilization to Address HIV Outbreaks Among At-Risk Populations. The Journal of Infectious Diseases 2017;215(10):1491
    CrossRef
  11. Thomann M, Grosso A, Zapata R, Chiasson MA. ‘WTF is PrEP?’: attitudes towards pre-exposure prophylaxis among men who have sex with men and transgender women in New York City. Culture, Health & Sexuality 2017;:1
    CrossRef